MISSION, Kan., June 16, 2025 /PRNewswire/ -- (Family Features) Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000-10,000 children. Despite its ...

The primary sign of growth hormone deficiency in children is short stature. Adults may have decreased muscle mass and increased body fat, as well as other problems such as heart disease and depression ...

Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

What Is Skytrofa, and Why Does It Matter? Skytrofa (lonapegsomatropin-tcgd) is a long-acting version of human growth hormone (hGH). It is already approved for children with growth hormone deficiency ...

Children with growth hormone deficiency (GHD) have differences in gut microbiota and microbial metabolites from both individuals with idiopathic short stature (ISS) and healthy controls, suggesting an ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...